
U.S. Plasmid Purification Market Size, Share & Trends Analysis Report By Product & Service (Instruments, Kits & Reagents), By Grade (Molecular Grade, Transfection Grade), By Application, By End Use, And Segment Forecasts, 2025 - 2033
Description
U.S. Plasmid Purification Market Trends
The U.S. plasmid purification market size was estimated at USD 699.4 million in 2024 and is projected to reach USD 1.84 billion by 2033, growing at a CAGR of 11.41% from 2025 to 2033. This growth is driven by increasing demand for gene therapy, vaccine development, and biopharmaceutical research, where high-quality plasmid DNA is critical.
U.S. Plasmid Purification Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. plasmid purification market based on product & service, grade, application, and end use:
The U.S. plasmid purification market size was estimated at USD 699.4 million in 2024 and is projected to reach USD 1.84 billion by 2033, growing at a CAGR of 11.41% from 2025 to 2033. This growth is driven by increasing demand for gene therapy, vaccine development, and biopharmaceutical research, where high-quality plasmid DNA is critical.
U.S. Plasmid Purification Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. plasmid purification market based on product & service, grade, application, and end use:
- Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
- Products
- Instruments
- Kits & Reagents
- Services
- Grade Outlook (Revenue, USD Million, 2021 - 2033)
- Molecular Grade
- Transfection Grade
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cloning & Protein Expression
- Transfection & Gene Editing
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Table of Contents
100 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Grade Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
- 1.3. Information Analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data Validation & Publishing
- 1.5. Information Procurement
- 1.5.1. Primary Research
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
- Chapter 3. U.S. Plasmid Purification Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Vaccine development (especially DNA vaccines)
- 3.2.1.2. Rise in biopharmaceutical R&D
- 3.2.2. Market restraint analysis
- 3.2.2.1. Ethical constraints related to the use of rDNA technology
- 3.3. U.S. Plasmid Purification Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTEL Analysis
- Chapter 4. U.S. Plasmid Purification Market: Product & Service Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. U.S. Plasmid Purification Market Product & Service Movement Analysis
- 4.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
- 4.4. Products
- 4.4.1. Products market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Instruments
- 4.4.2.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Kits & Reagents
- 4.4.3.1. Kits & reagents market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Services
- 4.5.1. Services market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 5. U.S. Plasmid Purification Market: Grade Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. U.S. Plasmid Purification Market Grade Movement Analysis
- 5.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Grade, 2021 to 2033 (USD Million)
- 5.4. Molecular Grade
- 5.4.1. Molecular-grade market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. Transfection Grade
- 5.5.1. Transfection grade market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 6. U.S. Plasmid Purification Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. U.S. Plasmid Purification Market Application Movement Analysis
- 6.3. U.S. Plasmid Purification Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 6.4. Cloning & Protein Expression
- 6.4.1. Cloning & protein expression market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Transfection & Gene Editing
- 6.5.1. Transfection & gene editing market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 7. U.S. Plasmid Purification Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. U.S. Plasmid Purification Market End Use Movement Analysis
- 7.3. U.S. Plasmid Purification Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Academic & Research Institutes
- 7.5.1. Academic & research institutes market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Contract Research Organizations
- 7.6.1. Contract research organizations market estimates and forecasts, 2021 - 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Merck KGaA
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product/Service benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. QIAGEN
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product/Service benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Thermo Fisher Scientific, Inc.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product/Service benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Takara Bio
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product/Service benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Promega Corporation
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product/Service benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Zymo Research
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product/Service benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. MP BIOMEDICALS
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product/Service benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. New England Biolabs
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product/Service benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. MCLAB
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product/Service benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Applied Biological Materials, Inc.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product/Service benchmarking
- 8.4.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.